Please assess the completion status of the following clinical trial:

Trial Title: Early Elimination of Premature Ventricular Contractions in Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with reduced ejection fraction (EF ≤45%) demonstrated by transthoracic echocardiogram and deemed to be non-ischemic by nuclear stress test or cardiac catheterization.~* Patients with \>20% PVCs on 24 hour holter-recording~* Patient is 18 years of age or older~* Optimized medical therapy on stable therapy for minimum 3 months with no changes in beta-blocker, ACE-I/ARB, digoxin doses (varying diuretic doses permitted).~Exclusion Criteria:~* Patients who are under the age of 18 years of age~* Patients with \>2 dominant PVC morphologies~* Patients with cardiac surgery in previous 3 months or scheduled for following 6 months~* Patients who were implanted with a biventricular device during the last three months or single/dual chamber device (with ventricular pacing \>10%) during the last three months~* Significant symptoms associated with PVCs that would make favor immediate ablation~* Intracardiac mural thrombus or myxoma~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ablation procedure vs medical therapy (Type: ACTIVE_COMPARATOR): PVC ablation vs medical therapy
- Compare 2 arms for safety, symptoms (Type: NO_INTERVENTION): Compare control of PVC's between 2 groups.

Based on this trial design, predict the completion outcome and termination type (if applicable).